CMPI

Checkmate Pharmaceuticals, Inc. Common Stock
CMPI

Delisted

CMPI was delisted on the 27th of May, 2022.

Back to rankings
 

About: Checkmate Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing its proprietary technology to harness the power of the immune system to combat cancer.

Employees: 31

Healthcare Drug Manufacturers - General
Charts implemented using Lightweight Charts™